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Abstracts / International Journal of Surgery 23 (2015) S15eS134S28option, with 40% willing to have neoadjuvant endocrine therapy to facili-
tate this. Only 14% would have considered neoadjuvant chemotherapy
with the same aim. Despite our BCS patients having to travel a consider-
able distance daily for radiotherapy, only 4% found it problematic. Eighty-
eight percent of patients who had BCS were happy with their treatment
decision, 72% being happy with the cosmetic outcome.
Conclusion: BCS is something that patients aged 70+ are interested in
considering. More than a third of mastectomy patients would be willing to
take neoadjuvant endocrine therapy to facilitate BCS.
0266: BREAST CANCER PRESENTATION IN THE OVER 70S
L. Smith*, J. Murray, A. Lannigan. Wishaw General Hospital, UK
Aim: To explore the presentation of the over 70s with breast cancer, along
with attitudes towards screening.
Methods: A questionnaire was sent to patients aged 70+ at breast cancer
diagnosis in NHS Lanarkshire between 2006 and 2013. This detailed rea-
sons and timing of presentation, in addition to thoughts about screening.
Results: Three hundred and ﬁfty-two questionnaires were sent with a 65%
response rate.
Sixty-four percent routinely examined themselves with 70% identifying a
lump themselves. Distressingly only 36% were aware of the other signs/
symptoms of breast cancer.
The majority of women sought medical attention early, with 39% pre-
senting within days, personal concern was the greatest prompt (68%).
Eighty-three percent routinely attended screening when invited, a further
3% willing to attend once over 70. The majority (60%) were not aware that
they could opt into the screening service when over 70.
Conclusion: Despite the belief that older women are less breast aware
most of our patients routinely examined themselves, identiﬁed pathology,
and promptly sought medical advice. Despite most women having no
knowledge of other signs and symptoms of breast cancer. Our cohort has
also shown that they are keen to continue screening over the age of 70 if it
was routinely offered.
0278: EVALUATING THE QUALITY OF INTERNET INFORMATION FOR
BREAST CANCER
A. Nghiem*, Y. Mahmoud, R. Som. Lewisham and Greenwich NHS Trust, UK
Aim: The internet is frequently used by patients for researching infor-
mation regarding breast cancer. Though much of it is contemporaneous
and of good quality, a signiﬁcant proportion of this information is un-
regulated, and potentially misleading. This study aims to assess the
quality of information on the internet regarding breast cancer using
validated tools.
Methods: The term 'breast cancer' was searched for in 3 search engines.
The top 20 results were selected and after duplicates and irrelevant
websites were excluded, the remaining websites were analysed using the
DISCERN Plus tool, HONcode and the JAMA benchmarks.
Results: 26 unique websites were assessed. The average score using the
DISCERN criteria was 57 out of a possible total of 80 e classed as ‘good’
(range: 25e74). Charity websites had the highest average score; 63 e
classed ‘excellent’. 9 websites were found to be HONcode certiﬁed. 7
websites complied with all four JAMA benchmarks.
Conclusion: This study shows the quality of breast cancer information on
the internet is on the whole good; however the range of quality is wide.
Patients may be heavily reliant on information available on the internet so
it is important for healthcare professionals involved in breast cancer care
to understand the nature of this information.
0290: AXILLARY STAGING IN BREAST CANCER: IMPROVEMENTS IN PRE-
OPERATIVE ULTRASOUND EVALUATION AT MUSGROVE PARK HOSPITAL
H. Weaver*, A. Brown, N. Atherton, S. Rahma, J. Gill, A. Thorne. Musgrove
Park Hospital, UK
Aim: NICE Guidelines (2009) advise that pre-treatment ultrasound eval-
uation of the axilla is undertaken for patients with early, invasive breast
cancer, and that ultrasound-guided needle sampling of any abnormalnodes should be performed. Pre-operative assessment of the axilla has
been standard practice at this unit since 2010. Our aim was to establish
whether rates of pre-operative diagnosis of axillary metastases have
changed since then.
Methods: Data were collected on all axillary procedures performed in
breast cancer patients between April 2010 and February 2014 at a busy
district general hospital. Cases were identiﬁed using consultant databases,
histopathology records and theatre diaries. Patients receiving neo-adju-
vant chemotherapy were excluded.
Results: 987 cases were identiﬁed. 279 patients had malignancy in the
axilla and 101 of these were diagnosed pre-operatively. The proportion of
patients with axillary malignancy diagnosed pre-operatively, as opposed
to using sentinel node biopsy, has increased year on year (21% in 2010-11;
37% in 2011e12; 48% in 2012e13 and 51% in 2013-14).
Conclusion: Over time, there has been a signiﬁcant trend towards diag-
nosing axillary malignancy pre-operatively rather than intra-operatively
on sentinel node biopsy. This suggests a learning curve in the use of
axillary ultrasound and node sampling in the unit.
0416: A RETROSPECTIVE ANALYSIS OF SURVIVAL AFTER BREAST
CANCER RECURRENCE: EVALUATION OF PREDICTIVE
CLINICOPATHOLOGICAL VARIABLES AND TREATMENT EFFECT
Y.K. Foo*, J. Byrne, R. Dave, E. Scott, Z. Kryjak, D. Ali. Pinderﬁelds General
Hospital, UK
Aim: To evaluate predictive clinicopathological variables of survival
following breast cancer recurrence.
Methods: All coded recurrences from January 2009 to January 2014
resulting from breast cancer resections from January 1988 to January 2013
were included in our study. Of the 272 patients identiﬁed, data was
available for 257 patients, and the clinicopathological variables were
analysed. The median follow-up was 9.40 years (IQR; 6.10e14.56). Survival
following recurrence was then calculated using log rank test.
Results: Survival following breast cancer recurrence was not predicted by
grade (p¼0.233), size (<50mm vs 50mm, p¼0.234) and hormone re-
ceptor status (ER+ve vs ER-ve; p¼0.873 and Triple negative; p¼0.224) of
the original tumour. There was no difference in the disease-free survival
between patients who developed distant and locoregional recurrence,
however, the overall survival following distant metastasis was 33.3
months, and that for locoregional disease was 54.6 months (n¼229,
p¼0.000). The majority of patients with locoregional disease (50/83) had
surgical management, and these patients had signiﬁcantly better post-
recurrence median survival (62 months) than those who had either
cytotoxic chemotherapy (33 months) or anti-hormone therapy (41
months).
Conclusion: Clinicopathological variables of the primary tumour cannot
predict recurrence; however aggressive surgical management of locore-
gional recurrence will improve survival compared to systemic therapy.
0451: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE INCIDENCE
AND PREDICTORS OF BLOOD TRANSFUSION IN BREAST
RECONSTRUCTION POST TRAM (TRANSVERSE RECTUS ABDOMINUS
MYOCUTANEOUS) FLAP AND DIEP (DEEP INFERIOR EPIGASTRIC
PERFORATOR) FLAP
S. Sepehripour a, G. Filobbos a,*, C. Malata b. aUniversity Hospital Coventry
and Warwickshire, UK; bAddenbrooke Hospital, UK
Aim: Despite the increase in number of women opting to have autologous
breast reconstruction with TRAM or DIEP ﬂaps, there is paucity in litera-
ture regarding the incidence and predictors of blood transfusion associated
with these procedures. The aim of the study is to conduct a systematic
review and meta-analysis of the incidence and predictors of blood trans-
fusion post TRAM and DIEP ﬂaps. To the best of our knowledge, this is the
only systematic review in literature on this topic.
Methods: Literature search conducted on Pubmed, Ovid medline and
EMBASE databases. Statistical analysis investigating odds ratio of trans-
fusion and correlation.
Results: The search identiﬁed 11 studies and no clinical trials. The reported
rate of transfusion ranges from 9.1% to 80.3% for DIEP and around 9% For
Abstracts / International Journal of Surgery 23 (2015) S15eS134 S29TRAM ﬂaps. The risk factors for transfusion include obesity, peri-operative
anaemia and bilateral cases. There are contradictory reports regarding
immediate procedures being a risk factor. The data is variable with lack of
consistency, emphasising the importance of a systematic analysis of the
studies.
Conclusion: We have identiﬁed the most common predictors for
post operative transfusion for DIEP and TRAM ﬂaps. This information is
valuable to patients and clinicians during preoperative counselling and
consent.
0495: IMPROVING POST OPERATIVE PAIN MANAGEMENT IN SUB-
PECTORAL TISSUE EXPANDER IMPLANT RECONSTRUCTION OF THE
BREAST USING AN ELASTOMERIC PUMP
S. Hallam*, A. Chaudhry, A. Chambers, S. Govindarajulu, A. Sahu, S.
Cawthorn. North Bristol NHS Trust, UK
Aim: Postoperative pain after breast surgery leads to delayed mobilization
and prolonged stay. We performed a retrospective analysis of patients
undergoing skin-sparing mastectomy and subpectoral implant recon-
struction. Hypothesis: Does the use of an elastomeric local anaesthetic
pump improve pain control and length of stay (LOS).
Methods: 25 consecutive patients undergoing the above procedure were
sited with an elastomeric local anaesthetic infusion pump intra-opera-
tively, in addition to standard regular and PRN analgesia. The control group
contained 25 patients undergoing the same procedure receiving standard
analgesia alone. Visual Analogue Scales (VAS) were recorded at 24 hours in
addition to PRN analgesic requirements.
Results: Median age was 51 (26e75) in the intervention group and 50
(28e70) in the control. Mean VAS score was 0.28 (0.61SD) at 24 hours in
the intervention group and 1.84 (0.37SD) in the control, p<0.0001. Mean
LOS was 1.8 days (0.71 SD), and 2.28 days (0.94 SD) in the control, p¼0.252.
There were no complications involving catheter placement, local anaes-
thetic leakage or toxicity.
Conclusion: We found signiﬁcantly reduced pain and trend towards
reduced and length of stay with the local anaesthetic infusion pump. The
elastomeric pump is a step towards enhanced patient recovery following
mastectomy and implant reconstruction.
0521: EXPLORING THE POTENTIAL OF USING THE TRAINEE
COLLABORATIVE MODEL TO DELIVER HIGH-QUALITY, LARGE-SCALE
PROSPECTIVE MULTICENTRE STUDIES IN RECONSTRUCTIVE BREAST
SURGERY: THE IBRA (IMPLANT BREAST RECONSTRUCTION
EVALUATION) STUDY
On behalf of the Breast Reconstruction Research CollaborativeBreast
Reconstruction Research Collaborative, United Kingdom
Aim: The introduction of techniques to augment the subpectoral pocket
has revolutionalised the practice of implant-based breast recon-
struction(IBBR), but evidence to support the safety and efﬁcacy of these
techniques is lacking. High-quality data are required, but large pro-
spective cohort-studies are expensive and time-consuming. Adoption of
the trainee research collaborative model may effectively overcome
these barriers.
We report early experience with the iBRA(implant Breast Reconstruction
evAluation) study which has employed this innovative methodology in
breast-surgery for the ﬁrst time.
Methods: The iBRA study has 4-phases that aim to inform the feasibility
and conduct of a future RCT including a national practice ques-
tionnaire(NPQ) and prospective audit.
Trainee leads have been identiﬁed at each centre via the Mammary Fold
and Reconstructive Surgery Trials Network. Leads are responsible for
completing the NPQ with the support of a lead consultant and identifying
patients for the prospective audit, collecting in-hospital and 30-day
outcome data and obtaining consent for patient-reported outcome
questionnaires.
Results: Between May-Dec2014, 67 units have completed the NPQ. Over
100 collaborators have recruited 328 patients from 35 centres and the
study is running 6-months ahead of schedule.Conclusion: The iBRA study has demonstrated that the trainee collabo-
rative model is an effective means delivering large-scale prospective
studies in breast-surgery.
0529: LOCAL RECURRENCE FOLLOWING BREAST CONSERVING SURGERY
FOR DUCTAL CARCINOMA IN-SITU: THE EDINBURGH EXPERIENCE
G.E. Ekatah*, M.J. Dixon. Western General Hospital Edinburgh, UK
Aim: Ductal carcinoma in-situ (DCIS) represents 5% of symptomatic and
50% of screen-detected breast malignancies. Historically managed with
mastectomy, providing excellent long-term outcomes, Breast Conserving
Surgery (BCS) +/ adjuvant radiotherapy now represents the mainstay
management option for DCIS providing better cosmetic outcomes with no
adverse impact on overall survival. The main drawback of BCS remains
local recurrence e DCIS or invasive breast cancer, which are associated
with signiﬁcant morbidity and mortality. Given advances in DCIS man-
agement, the study aims to compare local recurrence rates as well as ‘time
to recurrence’ over the last 10 years to previously published data from the
Edinburgh breast unit.
Methods: Retrospective single-centre study of patients with histologically
conﬁrmed primary DCIS who underwent BCS between January 2000 and
January 2010.
Results: Of the 477 eligible patients, 7.8% (n¼37) developed local recur-
rence following BCS (median follow-up ¼ 63months), a signiﬁcant
decrease from 15% previously reported within the same unit. The median
time-to-recurrence was 27months. There is also trend towards decreasing
local recurrence rates with increasing use of adjuvant radiotherapy.
Conclusion: Advances in DCIS management and widespread use of adju-
vant radiotherapy have contributed to a signiﬁcant reduction in local
recurrence rates following BCS for DCIS.
0530: EXPLORING VARIATIONS IN THE PROVISION AND PRACTICE OF
IMPLANT-BASED BREAST RECONSTRUCTION IN THE UK: INITIAL
RESULTS FROM THE IBRA NATIONAL PRACTICE QUESTIONNAIRE
On behalf of the Breast Reconstruction Research CollaborativeBreast
Reconstruction Research Collaborative, United Kingdom
Aim: The introduction of lower-pole sling-procedures has revolutionised
the practice of implant-based breast-reconstruction (IBBR), but data
regarding the availability and practice of these procedures is limited. The
iBRA (implant Breast Reconstruction evAluation) Study aims to explore the
practice and outcomes of IBBR to inform the feasibility of undertaking an
RCT comparing techniques.
We report the early results of iBRA Phase-1, a National Practice Ques-
tionnaire (NPQ) which aims to comprehensively describe current national-
practice.
Methods: A questionnaire developed by the iBRA Steering-Group was
completed by trainee and consultant leads at breast and plastic surgical-
units across the UK. Simple summary statistics were calculated and vari-
ations in service-provision, practice and adherence to guidelines
evaluated.
Results: 44-units have completed the NPQ to-date. Variation was
demonstrated in the provision of novel-techniques especially the avail-
ability of biological (n¼32, 72.7%) and synthetic (n¼10, 20.5%)meshes and
in patient-selection. There was lack of consistency in peri and post-oper-
ative management particularly duration of antibiotic-use (induction-only-
vs.14-day-course) and drain-policy (no-drains-vs.2-drains-for-14-days).
Few units (n¼14, 37.8%) had written management protocols and only half
(n¼20) prospectively-audited their outcomes.
Conclusion: Early analysis of the iBRA-NPQ has demonstrated marked
variation in the provision and practice of IBBR. Phase-2 of the iBRA Study
will determine the safety and efﬁcacy of different approaches to IBBR and
allow evidence-based best practice to be explored.
0571: ARTISS HUMAN FIBRIN SEALANT GLUE FOR MASTECTOMY FLAP
ADHERENCE
M. Venn*, E. Babu. The Hillingdon Hospitals NHS Foundation Trust, UK
